Trialbee Health

Today, Trialbee and uMotif announce their partnership to simplify and expand patient access to global clinical trials. This partnership will streamline the end-to-end patient journey through a lightweight, data-driven solution that removes the need for multiple apps or systems. The companies’ integrated platforms simplify trial activities from initial awareness through enrollment and data collection during study conduct and close-out, optimizing the patient experience. Techn...ology is changing the way clinical trials are run, presenting new opportunities to expand patient access, especially among historically underrepresented patient groups, and bring life saving drugs and devices to market efficiently and effectively, says @Matt Walz, CEO of Trialbee. Through this partnership, Trialbee and uMotif are transforming clinical trials to benefit global patients, trials sponsors, CROs, investigative sites and other stakeholders. https://trialbee.com/trialbee-and-umotif-simplify-and-expa/ #clinicaltrials #clinicalresearch

In Phase II and III trials across all therapeutic areas, 57% and 36% of subjects, respectively, fail to meet screening and randomisation criteria. Trial cycle times are also becoming longer due to lowering enrolment and retention associated with changing trends in protocol designs. Read this article to learn how @worldwide clinical trials and @trialbee are collaborating to boost enrollment. https://pst.cr/gULvp #patientrecruitment #decentralizedclinicaltrials #clinicalresearch #rwd

Our own Matt Walz writes about how leveraging Real World Data, decentralized trials, and diversity will enable the industry to put patients first in this recent article in Pharmaceutical Outsourcing. "Those operating remote trials can drive change for underrepresented or hard-to-reach populations by linking clinical data and RWD to bring down access barriers, and linking trial data to RWD can give researchers the data they seek and at the same time reduce the need for regul...ar in-person site visits. RWD can also be instrumental in uncovering inherent biases in previous research and ensuring they do not creep back to the surface of current research. This will also improve the overall quality of studies and a therapy’s benefit-risk profile in later stage drug development. https://www.pharmoutsourcing.com//576442-How-Real-World-D/ #patientrecruitment #decentralizedclinicaltrials #clinicalresearch #rwd

MTIP sat down with Trialbee Chief Strategy Officer, Lars-olof Eriksson to learn more about Trialbee and how we are innovating in the patient recruitment and enrollment industry. https://pst.cr/diKtS #patientrecruitment #clinicaltrials #trialbee #casestudy #biotech

As clinical research is increasingly moving to a decentralized model, it’s critical that the patient matching and enrollment process is streamlined and data-driven to speed the clinical trial process. Join Trialbee CEO Matt Walz and THREAD CEO John Reites on June 23rd at 12pm ET as they discuss the challenges of patient recruitment and enrollment in decentralized clinical trials. https://pst.cr/HWbTN #decentralizedclinicaltrials #patientrecruitment #clinicaltrials